China · Delayed Price · Currency is CNY Sinotherapeutics Statistics
Total Valuation
SHA:688247 has a market cap or net worth of CNY 3.57 billion. The enterprise value is 2.76 billion.
| Market Cap | 3.57B |
| Enterprise Value | 2.76B |
Important Dates
The last earnings date was Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Oct 23, 2026 |
Share Statistics
SHA:688247 has 449.00 million shares outstanding. The number of shares has decreased by -11.65% in one year.
| Current Share Class | 449.00M |
| Shares Outstanding | 449.00M |
| Shares Change (YoY) | -11.65% |
| Shares Change (QoQ) | -1.18% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 0.61% |
| Float | 112.29M |
Valuation Ratios
The trailing PE ratio is 180.60.
| PE Ratio | 180.60 |
| Forward PE | n/a |
| PS Ratio | 9.28 |
| PB Ratio | 2.80 |
| P/TBV Ratio | 2.86 |
| P/FCF Ratio | 46.23 |
| P/OCF Ratio | 34.81 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 125.24, with an EV/FCF ratio of 36.04.
| EV / Earnings | 158.93 |
| EV / Sales | 7.23 |
| EV / EBITDA | 125.24 |
| EV / EBIT | n/a |
| EV / FCF | 36.04 |
Financial Position
The company has a current ratio of 8.79, with a Debt / Equity ratio of 0.00.
| Current Ratio | 8.79 |
| Quick Ratio | 7.73 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.00 |
| Interest Coverage | -10,627.99 |
Financial Efficiency
Return on equity (ROE) is 1.38% and return on invested capital (ROIC) is -0.52%.
| Return on Equity (ROE) | 1.38% |
| Return on Assets (ROA) | -0.13% |
| Return on Invested Capital (ROIC) | -0.52% |
| Return on Capital Employed (ROCE) | -0.22% |
| Weighted Average Cost of Capital (WACC) | 5.44% |
| Revenue Per Employee | 1.25M |
| Profits Per Employee | 56,743 |
| Employee Count | 319 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 2.80 |
Taxes
In the past 12 months, SHA:688247 has paid 2.25 million in taxes.
| Income Tax | 2.25M |
| Effective Tax Rate | 11.07% |
Stock Price Statistics
The stock price has decreased by -25.07% in the last 52 weeks. The beta is 0.22, so SHA:688247's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | -25.07% |
| 50-Day Moving Average | 8.90 |
| 200-Day Moving Average | 9.19 |
| Relative Strength Index (RSI) | 41.19 |
| Average Volume (20 Days) | 5,128,895 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688247 had revenue of CNY 397.68 million and earned 18.10 million in profits. Earnings per share was 0.04.
| Revenue | 397.68M |
| Gross Profit | 140.50M |
| Operating Income | -2.97M |
| Pretax Income | 20.35M |
| Net Income | 18.10M |
| EBITDA | 22.90M |
| EBIT | -2.97M |
| Earnings Per Share (EPS) | 0.04 |
Balance Sheet
The company has 814.03 million in cash and 38,666 in debt, with a net cash position of 813.99 million or 1.81 per share.
| Cash & Cash Equivalents | 814.03M |
| Total Debt | 38,666 |
| Net Cash | 813.99M |
| Net Cash Per Share | 1.81 |
| Equity (Book Value) | 1.32B |
| Book Value Per Share | 3.07 |
| Working Capital | 879.94M |
Cash Flow
In the last 12 months, operating cash flow was 106.04 million and capital expenditures -26.21 million, giving a free cash flow of 79.83 million.
| Operating Cash Flow | 106.04M |
| Capital Expenditures | -26.21M |
| Depreciation & Amortization | 25.87M |
| Net Borrowing | -68,298 |
| Free Cash Flow | 79.83M |
| FCF Per Share | 0.18 |
Margins
Gross margin is 35.33%, with operating and profit margins of -0.75% and 4.55%.
| Gross Margin | 35.33% |
| Operating Margin | -0.75% |
| Pretax Margin | 5.12% |
| Profit Margin | 4.55% |
| EBITDA Margin | 5.76% |
| EBIT Margin | -0.75% |
| FCF Margin | 20.07% |
Dividends & Yields
This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 0.44%.
| Dividend Per Share | 0.04 |
| Dividend Yield | 0.44% |
| Dividend Growth (YoY) | -59.68% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 86.82% |
| FCF Payout Ratio | 14.06% |
| Buyback Yield | 11.65% |
| Shareholder Yield | 12.08% |
| Earnings Yield | 0.55% |
| FCF Yield | 2.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |